Supervised physical activity in patients with symptomatic peripheral arterial disease: protocol for a randomized clinical trial (ARTPERfit Study).

Clinical trials Medical education & training Primary care Protocols & guidelines Sports medicine Vascular medicine

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
27 04 2022
Historique:
entrez: 28 4 2022
pubmed: 29 4 2022
medline: 30 4 2022
Statut: epublish

Résumé

Peripheral arterial disease (PAD) is a marker of cardiovascular morbidity, causing disability, loss of mobility and poor quality of life, manifesting clinically in the form of intermittent claudication (IC). Physical exercise increases the distance walked and improves quality of life. The aim of our study will be increased walking distance prolonging the time of onset of pain in patients with symptomatic PAD (IC). This study will be performed in Mataró Hospital's vascular surgery service and School of Health Sciences, TecnoCampus. This population comes from 15 primary healthcare centres ofNorth Barcelona, Spain (450 000 inhabitants).This study will be a four-group parallel, longitudinal, randomised controlled trial, blind to analysis.The main primary outcome of this study will be the improvement in pain-free walking distance. Others primary objectives are and improvement in functional status, quality of life and Ankle-Brachial Index (ABI). Secondary outcomes will be the analysis of cardiorespiratory fitness, evaluation of muscle fitness, determine the maintenance of primary objectives at 6 and 12 months.We will be included 124 patients (31 per group). The changes of the outcome (Barthel, SF-12, VascQOL-6, ABI) of the three intervention groups vs the control group at 3, 6 and 12 months will be compared, both continuously (linear regression) and categorically (logistic regression). A person who has not performed at least 75% of the training will be considered to have not completed the intervention. The study will be conducted according to the Declaration of Helsinki . It was approved by the Ethics Committee of the Research Institute Primary Health IDIAP Jordi Gol (20/035 P),Barcelona 6 October 2020. Informed consent will be obtained from all patients before the start of the study. We will disseminate results through academic papers and conference presentations. NCT04578990.

Identifiants

pubmed: 35477870
pii: bmjopen-2021-054352
doi: 10.1136/bmjopen-2021-054352
pmc: PMC9047770
doi:

Banques de données

ClinicalTrials.gov
['NCT04578990']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e054352

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Circulation. 1990 Feb;81(2):602-9
pubmed: 2404633
JAMA. 2008 Jul 9;300(2):197-208
pubmed: 18612117
Med Sci Sports Exerc. 2000 Oct;32(10):1777-82
pubmed: 11039652
Int Angiol. 2009 Feb;28(1):20-5
pubmed: 19190551
J Vasc Surg. 2004 Mar;39(3):523-30
pubmed: 14981443
J Vasc Surg. 2015 Sep;62(3):689-97
pubmed: 25953022
Scand J Med Sci Sports. 2011 Dec;21(6):e308-14
pubmed: 21410546
J Am Geriatr Soc. 2004 Mar;52(3):405-10
pubmed: 14962156
JAMA. 2009 Jan 14;301(2):165-74
pubmed: 19141764
Br J Sports Med. 2020 Apr;54(8):452-461
pubmed: 30979698
Scand J Rehabil Med. 1970;2(2):92-8
pubmed: 5523831
Health Qual Life Outcomes. 2013 Oct 22;11:175
pubmed: 24148832
J Vasc Surg. 2010 Nov;52(5):1196-202
pubmed: 20674247
Rev Esp Cardiol (Engl Ed). 2012 Aug;65(8):726-33
pubmed: 22727799
Vasa. 2019 Sep;48(Suppl 102):1-79
pubmed: 31789115
Vasc Med. 2008 Feb;13(1):15-24
pubmed: 18372434
Circulation. 2017 Mar 21;135(12):e726-e779
pubmed: 27840333
Front Physiol. 2020 Jan 08;10:1538
pubmed: 31969830
Vasc Endovascular Surg. 2011 Nov;45(8):703-11
pubmed: 21914680
Int J Epidemiol. 1991 Jun;20(2):384-92
pubmed: 1917239
Am Heart J. 2015 Jun;169(6):924-937.e3
pubmed: 26027632
Lancet Glob Health. 2020 May;8(5):e721-e729
pubmed: 32353319
Angiology. 1999 Mar;50(3):193-200
pubmed: 10088798
Vasc Med. 2018 Aug;23(4):349-357
pubmed: 29671381
Int J Sports Med. 2018 Feb;39(2):115-123
pubmed: 29190852
J Vasc Surg. 1997 Sep;26(3):517-38
pubmed: 9308598
J Gerontol A Biol Sci Med Sci. 2001 Jul;56(7):B302-10
pubmed: 11445595
BMC Public Health. 2010 Jan 27;10:38
pubmed: 20529387
J Am Coll Cardiol. 2010 Oct 26;56(18):1506-12
pubmed: 20951328
PLoS One. 2019 Jan 7;14(1):e0210292
pubmed: 30615666
Int J Sports Med. 2005 Feb;26 Suppl 1:S38-48
pubmed: 15702455
J Am Geriatr Soc. 2011 Oct;59(10):1855-63
pubmed: 22091499
J Vasc Surg. 2013 Apr;57(4):963-973.e1
pubmed: 23246081
Glob Heart. 2014 Mar;9(1):145-158.e21
pubmed: 25432124
Cochrane Database Syst Rev. 2017 Dec 26;12:CD000990
pubmed: 29278423
Atherosclerosis. 2004 Jan;172(1):95-105
pubmed: 14709362
Eur J Vasc Endovasc Surg. 2009 Sep;38(3):305-11
pubmed: 19515589

Auteurs

Maria Teresa Alzamora (MT)

Family Medicine Riu Nord-Riu Sud, Institut Català de la Salut, Santa Coloma de Gramenet, Spain maiteal2007@gmail.com.
USR Metropolitana Nord, IDIAP Jordi Gol, Barcelona, Spain.

Rosa Forés (R)

USR Metropolitana Nord, IDIAP Jordi Gol, Barcelona, Spain.
Family Medicine Riu Nord-Riu Sud. Santa Coloma de Gramenet, Institut Català de la Salut, Barcelona, Spain.

Noemi Serra (N)

Universitat Pompeu Fabra Escola Superior Politècnica del TecnoCampus, Mataro, Spain.

Esau Martinez (E)

Vascular Surgery, Hospital de Mataró, Mataro, Spain.

Guillem Pera (G)

USR Metropolitana Nord. Mataró, IDIAP Jordi Gol, Barcelona, Spain.

Gemma Seda (G)

Institut Catala De La Salut, Barcelona, Spain.

Joan Lopez Palencia (J)

Vascular Surgery, Hospital de Mataró, Mataro, Spain.

Manuel Gomis (M)

Universitat Pompeu Fabra Escola Superior Politècnica del TecnoCampus, Mataro, Spain.

Antonio Heras Tébar (A)

USR Metropolitana Nord, IDIAP Jordi Gol, Barcelona, Spain.
Primary Healthcare Center Riu Nord-Riu SUD, Institut Catala De La Salut, Barcelona, Spain.

Marta Valverde (M)

Hospital Nostra Senyora de Meritxell, Escaldes-Engordany, Andorra.

Manuel Vicente Garnacho (MV)

Universitat Pompeu Fabra Escola Superior de Ciències de la Salut TecnoCampus, Mataro, Spain.

Pere Torán (P)

Unitat de Suport a la Recerca Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH